Thromboembolic risk of patients referred for radiofrequency catheter ablation of typical atrial flutter without prior appropriate anticoagulation therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 1 II, 2003, Pages 323-327

  Grönefeld, Gerian C ^a   Wegener, Florian ^a   Israel, Carsten W ^a   Teupe, Claudius ^a   Hohnloser, Stefan H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Anticoagulants; Atrial fibrillation; Atrial flutter; Radiofrequency ablation; Thromboembolism

Indexed keywords

ADULT; AGED; ANTICOAGULANT THERAPY; CATHETER ABLATION; CONFERENCE PAPER; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOGENESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

EID: 0037253056     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00042.x     Document Type: Conference Paper

References (20)

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154:1449-1457.
2. Albers GW. Dalen JE, Laupacis A, et al. Antithrombotic therapy in atrial fibrillation. Chest 2001; 119:194S-206S.
3. Laupacis A, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibrillation. Chest 1995; 108:352S-359S.
4. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. Circulation 2001; 104:2118-2150.
5. ASHP therapeutic position statement on antithrombotic therapy in chronic atrial fibrillation. American Society of Health-System Pharmacists. Am J Health Syst Pharm 1998; 55:376-381.
6. Corrado G, Sgalambro A, Mantero A, et al. Thromboembolic risk in atrial flutter. The FLASIEC (FLutter Atriale Societa Italiana di Ecografia Cardiovascolare) multicentre study. Eur Heart J 2001; 22:1042-1051.
7. Wood KA, Eisenberg SJ, Kalman JM, et al. Risk of thromboembolism in chronic atrial flutter. Am J Cardiol 1997; 79:1043-1047.
8. Lanzarotti CJ, Olshansky B. Thromboembolism in chronic atrial flutter: is the risk underestimated? J Am Coll Cardiol 1997; 30:1506-1511.
9. Grimm RA, Stewart WJ, Arheart K, et al. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: An attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol 1997; 29:582-589.
10. Zabalgoitia M, Halperin JL, Pearce LA, et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation, Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol. 1998; 31:1622-1626.
11. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998; 128:639-647.
12. Weiss R, Marcovitz P, Knight BP, et al. Acute changes in spontaneous echo contrast and atrial function after cardioversion of persistent atrial flutter. Am J Cardiol 1998; 82:1052-1055.
13. Schmidt H, von der RG, Illien S, et al. Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol 2001; 38:778-784.
14. Seidl K, Hauer B, Schwick NG, et al. Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol 1998; 82:580-583.
15. Liaudet L, Kehtari R, Enrico JF. Cerebral thromboembolism after direct current cardioversion for pure atrial flutter. Intensive Care Med 1997; 23:196-197.
16. Rozenberg V, Boccara F, Benhalima B, et al. Comparison of echocardiographic markers of embolism in atrial flutter and fibrillation: Frequency of protruding atherosclerotic plaques in the thoracic aorta. Echocardiograph. 2000; 17:555-562.
17. Roithinger FX, Karch MR, Steiner PR, et al. Relationship between atrial fibrillation and typical atrial flutter in humans: Activation sequence changes during spontaneous conversion. Circulation 1997; 96:3484-3491.
18. Ortiz J, Niwano S, Abe H, et al. Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms. Circ Res 1994; 74:882-894.
19. Philippon F, Plumb VJ, Epstein AE, et al. The risk of atrial fibrillation following radiofrequency catheter ablation of atrial flutter, Circulation 1995; 92:430-435.
20. Loutrianakis E, Barakat T, Olshansky B. Early versus late atrial fibrillation after atrial flutter ablation. J Interv Card Electrophysiol 2002; 6:173-180.